Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OBLN

Obalon Therapeutics (OBLN) Stock Price, News & Analysis

Obalon Therapeutics logo

About Obalon Therapeutics Stock (NASDAQ:OBLN)

Advanced Chart

Key Stats

Today's Range
$2.36
$2.50
50-Day Range
$2.36
$7.64
52-Week Range
$0.66
$10.77
Volume
126,096 shs
Average Volume
7.68 million shs
Market Capitalization
$23.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OBLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Obalon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OBLN Stock News Headlines

InterWest Management Partners X, LLC's Net Worth
Obalon Therapeutics, Inc.
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Spero Therapeutics Inc.
Renovare Environmental Inc (RENO)
See More Headlines

OBLN Stock Analysis - Frequently Asked Questions

Obalon Therapeutics, Inc. (NASDAQ:OBLN) posted its quarterly earnings results on Thursday, March, 11th. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.11. The company earned $0.06 million during the quarter. Obalon Therapeutics had a negative trailing twelve-month return on equity of 161.38% and a negative net margin of 776.76%.

Obalon Therapeutics's stock reverse split on the morning of Thursday, July 25th 2019.The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Obalon Therapeutics (OBLN) raised $75 million in an initial public offering (IPO) on Thursday, October 6th 2016. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. UBS Investment Bank, Canaccord Genuity and Stifel acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Obalon Therapeutics investors own include Inovio Pharmaceuticals (INO), Vaxart (VXRT), Canopy Growth (CGC), Plug Power (PLUG), NIO (NIO), NVIDIA (NVDA) and OPKO Health (OPK).

Company Calendar

Last Earnings
3/11/2021
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OBLN
CIK
1427570
Fax
N/A
Employees
2
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.33 million
Net Margins
-776.76%
Pretax Margin
N/A
Return on Equity
-161.38%
Return on Assets
-83.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.86
Quick Ratio
1.86

Sales & Book Value

Annual Sales
$1.59 million
Price / Sales
15.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
3.97

Miscellaneous

Outstanding Shares
10,022,000
Free Float
N/A
Market Cap
$23.85 million
Optionable
Not Optionable
Beta
-1.23

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:OBLN) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners